Carregant...

Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome

PURPOSE: To assess the anatomical outcome of patients with exudative age-related macular degeneration resistant to ranibizumab treated with aflibercept. METHOD: Prospective, interventional, case series, where we treated a group of patients deemed resistant to Ranibizumab after 6 months of persistenc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Saudi J Ophthalmol
Autor principal: Abou-Ltaif, Sleiman
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161818/
https://ncbi.nlm.nih.gov/pubmed/28003780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjopt.2016.10.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!